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a b s t r a c t
Whether alexithymia is a personality trait which increases the risk of Panic Disorder (PD) is still debated.
In this prospective study, alexithymic levels were evaluated before, during and after an anxious episode.
Therefore, the alexithymic levels, the presence of PD and the severity of anxious-depressive symptoms
were evaluated, at intervals of about 1 month, in pregnant women, attending the Centers for Prenatal
Care, using the Toronto Alexithymia Scale (TAS-20), the Primary Care Evaluation of Mental Disorders and
the Hospital Anxiety and Depression Scale (HADS). Twenty-one women affected by PD and 256 healthy
women (controls) were included in the study. Women who developed PD, compared to controls, showed
similar TAS-20 and HADS scores during the pre-morbid phase, a signiﬁcant increase of them during PD
and a signiﬁcant decrease after symptoms improvement, whereas no change was observed in controls.
Our data suggest that in pregnant women alexithymia does not represent a personality trait that
increases the risk of developing PD, and they support the hypothesis that alexithymia is a state
dependent phenomenon in PD pregnant women.
& 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
A personality characterized by difﬁculty to process or regulate
emotions using cognitive strategies (alexithymia) is supposed to
increase the risk for mental disorders such as major depression
(Celikel et al., 2010), panic disorder (Marchesi et al., 2005), eating
disorders (Carano et al., 2006) and substances abuse (de Timary
et al., 2008).
Concerning Panic Disorder (PD), high rates of alexithymia have
been found in PD patients (Parker et al., 1993; Zeitlin and McNally,
1993; Cox et al., 1995; Bankier et al., 2001; Iancu et al., 2001;
Marchesi et al., 2000, 2005). This ﬁnding was explained by
different hypotheses: (1) alexithymia, as a personality trait,
precedes and predisposes people to PD (Parker and Taylor, 1997);
(2) alexithymia is nothing more than a state reaction (secondary
alexithymia), which mitigates painful affects in patients with a
mental disorder (Freyberger, 1977; Ahrens and Deffner, 1986; Wise
et al., 1990) and (3) the large proportion of PD patients reporting
high TAS-20 score should not be considered alexithymic because a
conceptual and psychometric overlap may exist between alexithy-
mia and cognitive aspects of PD (Cox et al., 1995; Marchesi et al.,
2005).
This controversy might be resolved with longitudinal studies
by evaluating alexithymia in PD patients before and after remis-
sion. At present, we have knowledge of only three longitudinal
studies (Fukunishi et al., 1997; Marchesi et al., 2005; Rufer et al.,
2010). In the ﬁrst and the second study (Fukunishi et al., 1997;
Marchesi et al., 2005) the TAS-20 score decreased after treatment
and the decrease was signiﬁcantly related to reduction of anxiety,
suggesting that alexithymia should be considered a state reaction.
In the third study (Rufer et al., 2010), similar results were found,
whereas the authors’ conclusions were somewhat different since
they claim that alexithymia is a“ complex manifestation that
includes both trait and state components”.
These longitudinal studies questioned the absolute stability of
alexithimia, which implies that no signiﬁcant changes should be
observed over time, and they suggested that alexithymia is
characterized by a state component. However, some authors
(Luminet et al., 2001; Taylor and Bagby, 2004; Saarijärvi et al.,
2006; Lumley et al., 2007) claim that the reduction of alexithymic
levels with the improvement of symptoms severity should not be
considered a ﬁnding against the trait hypothesis, since if the
relative differences in alexithymic scores remain the same among
patients (relative stability) the trait hypothesis is conﬁrmed.
Therefore, the relative stability is supposed to be a characteristic
of alexithymia as personality trait in their view. Nevertheless, the
relative stability does not provide any information regarding the
pre-morbid alexithymic levels in PD patients and then it cannot
represent a conclusive ﬁnding supporting the trait hypothesis. This
conclusion was also stated by Mikolajczak and Luminet (2006)
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(two authors supporting the trait hypothesis), who claimed that
“the stability of alexithymia scores at follow-up would not con-
stitute evidence that alexithymia preceded mental disorder”.
In our knowledge no studies have investigated alexithymia in a
premorbid phase of PD.
Therefore, the present study was aimed to verify how alexithymic
levels were before, during and after a PD episode. For this purpose we
evaluated alexithymia and the presence of an episode of PD in a
sample of women, attending the Centers for Prenatal Care, at
approximately monthly intervals during the whole pregnancy.
2. Methods
The study protocol was approved by the Local Ethical Committee.
2.1. Sample
The study population was recruited among women who consecutively sought
assistance at the Centers for Prenatal Care of the Public Health Service of District of
Mantova (Italy), from September 2005, and Reggio Emilia (Italy), from January 2007.
Women participated in the study after the procedure had been fully explained
and a written informed consent was obtained, if they were older than 18 years and
completed all the evaluations from the beginning of their pregnancy.
The study included 299 women. Twenty-two women were excluded from the
study because they presented during pregnancy anxious symptoms, which did not
satisfy the diagnostic criteria of PD: the criteria of Generalized Anxiety Disorder
(GAD) were satisﬁed in six women and those of anxiety disorder not otherwise
speciﬁed (NOS) in 16. These women were excluded from the study because it was
aimed to evaluate alexithymia before, during and after the episodic manifestations
of an anxiety disorder, and PD seems the only disorders, diagnosed with the
PRIME-MD (PD, GAD and anxiety disorder NOS)(see assessment), which presents
this characteristic.
Therefore the study population included 277 women: 21 were diagnosed as
affected by PD and the remaining 256 did not present anxious symptoms during
pregnancy (healthy controls)(C).
2.2. Assessment
At each visit, all women were asked to complete (approximately every month)
the following evaluations: (1) the Italian translation of the Primary Care Evaluation
of Mental Disorders (PRIME-MD) (Spitzer et al., 1994), for the screening of PD; (2)
the Italian translation of the Hospital Anxiety and Depression Scale (HADS)
(Zigmond and Snaith, 1983) for the evaluation of severity of anxious and depressive
symptoms and (3) the Italian version of the TAS-20 (Bressi et al., 1996), for the
assessment of alexithymic levels.
Moreover, all women completed a brief questionnaire, performed ad hoc, to
collect socio-demographic and anamnesis information.
The PRIME-MD is a structured interview for the diagnosis of mental disorders
according to the criteria of DSM-IV (American Psychiatric Association, 1994), and
was administered at each visit by the gynecologists, who were trained by a senior
psychiatrist. Three anxiety disorders can be diagnosed with the PRIME-MD: PD,
GAD and anxiety disorder NOS.
A woman was deﬁned as affected by PD if, at any evaluation during pregnancy,
she fulﬁlled the criteria for a PD episode. A womanwas deﬁned as healthy control if
she did not present any anxious symptoms at any evaluation during pregnancy.
The TAS-20 is the most widely used measure of the alexithymia construct. It is a
self-rated questionnaire, composed by 20 items that are rated on a ﬁve-point Likert
scale. The items load on three factors: Difﬁcult in Identifying Feeling (DIF), Difﬁcult
in Describing Feeling (DDF) and Externally Oriented Thinking (EOT).
The HADS is a self-administered instrument for the evaluation of anxiety and
depression in a non-psychiatric population. The seven items of the depression
subscale were largely based on the anhedonic state: in fact, ﬁve items are related to
the loss of pleasure. The seven items of the anxiety subscale were chosen from the
psychic manifestations of anxiety. Therefore, HADS generates two subscale scores:
the anxiety score and the depression score.
2.3. Statistical analysis
Comparisons between PD and C women were performed using the two-tailed
Student t-test, for continuous variables and with the χ2 test for categorical variables.
One-way analysis of variance for repeated measures was used to evaluate
whether TAS-20 and HADS subscales scores changed during pregnancy in C and in
PD women.
Two-tailed Student t-test was used to compare TAS-20 and HADS subscale
scores in the two groups of women. Three comparisons of TAS-20 and HADS
subscales scores were performed between PD and C women. The evaluations
before, during and after the acute anxious episode were used for PD women. When
more than one evaluation was available before or after the anxious episode, we
used the evaluation corresponding to the lowest severity of anxious symptoms,
whereas if more than one evaluation was available during PD we used that
corresponding to the highest severity of anxiety symptoms. For C women we used
the evaluations corresponding to the same time of those of PD women, because
they did not show any signiﬁcant change in TAS-20 and HADS subscales scores
during pregnancy (see results).
To test the relative stability of alexithymia in PD women, a stepwise linear
regression analysis (forward selection) was used: in the analysis, TAS-20 total
scores after anxious symptoms improvement were used as dependent variable and
TAS-20 total scores before and during PD and HADS subscale scores after anxious
symptoms improvement were used as independent variables.
An analysis of covariance was used to evaluated whether the difference in TAS-
20 scores (dependent variable) between PD women during the anxious phase and C
women (independent variable) were still present after controlling for the HADS
subscale scores (covariates).
Finally, logistic regression (enter method) was used to test whether the TAS-20
scores at the beginning of pregnancy (used as independent variable) predicted the
development of PD during pregnancy (presence or absence of PD was used as
dependent variable).
3. Results
3.1. Sample
The study included 299 women with a mean age of 30.774.4
years (18–45 years). Twenty-two women were excluded from the
study because they presented during pregnancy anxious symp-
toms, which did not satisfy the diagnostic criteria of PD (GAD or
anxiety disorder not otherwise speciﬁed). Therefore the study
population included 277 women: 21 were diagnosed as affected by
PD and the remaining 256 were did not present anxious symp-
toms during pregnancy (C). PD and C women showed the same
age, years of education and family or occupational status (Table 1).
The PD symptoms became evident after 4.072.1 months of
pregnancy and they lasted for 3.072 months (Table 1).
Table 1
Socio-demographic and clinical features in pregnant women who developed panic
disorder. and in healthy pregnant women.
Panic disorder No anxiety
n. 21 n. 256
Age (years)(mean7S.D.) 31.973.9 30.774.4 t¼1.2 p¼0.23
Education (years)
(mean7S.D.)
11.073.1 12.373.3 t¼1.7 p¼0.08
Family status χ2¼4.7 p¼0.58
Never married 2 (9.5%) 41 (16.0%)
Married 18 (85.7%) 186 (72.7%)
Living together 1 (4.8%) 27 (10.5%)
Separated/divorced – 2 (0.8%)
Occupation χ2¼4.3 p¼0.21
Unemployed 0 1 (0.8%)
Student 0 2 (1.7%)
Housewife 6 (37.5%) 8 (7.1%)
Employed 10 (62.5%) 101 (90.1%)
Number of assessments
Total (mean7S.D.) 6.171.3 6.071.3 t¼0.43 p¼0.66
Before PD 2.972.9 –
After PD 2.272.2 –
Anxious episode (mean7S.D.)
Time of onset (months) 4.072.1 –
Duration (months) 3.071.2 –
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3.2. Treatment
None of the PD women received a pharmacological treatment
and only three women were treated with cognitive-behaviour
therapy because the severity of anxious symptoms. However, at
each visit, PD women received a psychological support given only
in non-standardized manner and they were encouraged to expose
themselves to the threatening situations.
3.3. Assessment
The number of assessments was similar in PD and in C women
(Table 1).
3.3.1. Alexithymia and symptom severity
The TAS-20 and the HADS subscales scores in PD women
(before, during and after the anxious episode) and in controls
are presented in Table 2. C did not show any change in the TAS-20
and HADS subscale scores across all evaluations, whereas, in
women who developed PD symptoms the pre-morbid TAS-20
and HADS scores were similar to those observed in C women,
they signiﬁcantly increased during the acute phase of PD and
decreased after symptoms improvement (Table 2).
Logistic regression analysis showed that TAS-20 score at the
beginning of pregnancy did not predict the development of PD
during pregnancy (wald¼0.01; p¼0.98; OR¼1.00; CI 95%¼0.94–
1.06).
In PD women, linear regression analysis showed that the TAS-
20 total scores after symptoms improvement were positively
related to the alexithymic levels observed during acute PD phase
(b¼0.54; t¼6.6; po0.001), but not to pre-morbid levels (b¼0.04;
t¼0.5; p¼0.56), controlling the effect of symptom severity after
improvement (HADS-A: b¼0.14; t¼1.9; p¼0.05).
Finally, the differences in TAS-20 score observed between PD
women, both during illness phase and symptoms improvement,
and C disappeared after controlling for the severity of anxiety and
depressive symptoms (ANCOVA: F¼1.34; d.f.¼1,273; p¼0.24 and
F¼0.22; d.f.¼1,273; p¼0.63, respectively).
4. Discussion
To our knowledge, this is the ﬁrst prospective study investigat-
ing premorbid alexithymic levels in women with an episode of PD.
In C women alexithymic levels did not change during the whole
pregnancy. In contrast, in PD women during the pre-morbid
period the alexithymic levels were similar to those of women
who maintained a healthy condition and, at the beginning of
pregnancy, the TAS-20 scores did not predict the development of
PD. Moreover, in PD women alexithymic levels signiﬁcantly
increased during the acute phase of illness and signiﬁcantly
decreased after symptoms improvement (even though higher
levels were still present). Finally, in PD women after symptoms
improvement, alexithymic levels were positively related to the
TAS-20 scores during PD (but not to pre-morbid scores) and to the
severity of residual anxiety symptoms.
All together our data suggest that in pregnant women alex-
ithymia does not represent a personality trait that increases the
risk to develop PD episode, and they support the hypothesis that
alexithymia is a state dependent phenomenon. According to the
state-hypothesis, in our study alexithymia levels were in the
normal range before the PD onset, increased as anxiety became
clinically relevant and decreased after the improvement of
symptoms.
Some authors (Taylor and Bagby, 2004; Lumley et al., 2007;
Rufer et al., 2010) suggest that alexithymia, as a personality trait, is
characterized by relative stability: even though the alexithymic
levels can decrease from the acute to the remission phase, the
relative differences among individuals remain stable over time.
This hypothesis implies that the basic personality conditions,
which constitute a predispositional factor to an anxiety disorder,
are accentuated by the state of illness and return to the
pre-existing conditions after remission, as suggested by Hoffart
(1994) in his predisposition-state model. However, to our knowl-
edge no previous study has demonstrated that the alexithymic
levels observed in the remitted state corresponded to those of the
pre-morbid phase.
Also in our study alexithymia showed a relative stability;
however, our data demonstrated that TAS-20 score assessed after
improvement of PD symptoms did not represent a return to the
Table 2
TAS-20 and HADS scores in women who developed Panic Disorder (PD) during pregnancy and in healthy pregnant women (C).
Scores mean7S.D. T1 vs. T2 vs. T3 PD vs. C
T1 T2 T3 One-way ANOVA for repeated measures t-test d.f.¼275
TAS-20 F p T1 T2 T3
PD (n. 21) 36.7710.1 62.179.0 45.3713.2 7.7 0.009 t 1.0 9.5 4.3
C (n. 256) 34.579.0 37.2711.8 35.279.9 0.8 0.44 p 0.29 o0.001 o0.001
DIF
PD 11.674.1 21.276.9 14.476.3 5.5 0.03 t 0.7 6.2 2.3
C 10.674.9 11.275.4 10.774.3 0.4 0.62 p 0.45 o0.001 0.02
DCF
PD 9.674.3 15.175.4 9.274.6 4.1 0.04 t 0.3 4.4 0.1
C 9.273.5 9.674.1 9.173.8 0.9 0.40 p 0.73 o0.001 0.92
EOT
PD 15.574.9 22.274.4 16.274.4 10.2 0.004 t 6 3.7 0.42
C 16.675.1 16.875.1 17.375.4 0.2 0.81 p 0.49 o0.001 0.66
HADS-A
PD 3.873.4 11.273.0 6.873.0 9.3 0.003 t 0.6 9.9 3.2
C 3.272.5 3.372.7 3.172.5 0.3 0.73 p 0.53 o0.001 0.002
HADS-D
PD 3.271.7 6.872.6 4.672.8 8.2 0.007 t 0.7 8.4 3.3
C 2.872.8 2.972.5 2.772.6 0.4 0.68 p 0.48 o0.001 0.002
HADS-A: anxiety subscale score, HADS-D: depression subscale score, T1: before the onset of anxiety episode in PD women, T2: during anxiety episode in PD women, T3: after
symptoms improvement in PD women, In C women T1, T2 and T3 represent the evaluations assessed at the same time of those of women with PD.
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pre-morbid conditions, because at this time a residual anxiety
symptoms can maintain an elevation of alexithymic levels, as
suggested by a positive relationship between HADS-A and TAS-20
scores after symptoms improvement. Therefore, our study
suggests that in patients affected by PD the alexithymic reaction
might resolve only after many months of remission, when also
residual symptoms disappeared and symptom severity returned to
the pre-morbid level. Otherwise, the presence of residual anxiety
symptoms seems a sufﬁcient condition to prevent the normal-
ization of the alexithymic reaction.
Therefore, our data do not conﬁrm that relative stability is a
ﬁnding supporting the hypothesis of alexithymia as a personality
trait, and they suggest that relative stability of alexithymia in PD
patients is the results of a parallel change between symptoms
severity and alexithymic scores, which wax and wane together.
The hypothesis that alexithymic levels were modulated by the
severity of symptoms is also supported by the disappearance of
the differences in TAS-20 scores observed between PD women
during the illness phase and in partial remission phase and C
women after controlling for symptom severity. Therefore, our data
conﬁrm both the suggestion of Hoffart (1994), who claimed that to
support the hypothesis that a personality feature constitutes a
predispositional factor to one disorder, the personality differences
observed between diagnostic groups should persist after symptom
severity has been controlled for, and that of Lumley (2000), who
stated that the uniqueness of the TAS-20 in the relationship with
anxiety could be tested by statistically controlling the other
construct and examining the residual relationship of the TAS-20
with the criterion.
There are at least two alternative explanations for the relation-
ship between alexithymia and PD observed in our study. Alex-
ithymia may be a temporary response to stress represented by a
PD episode; in this view “secondary alexithymia” can represent a
defense or a strategy to cope with distress (emotional pain and
physiological arousal) associated with PD (Lumley, 2000). In the
second view, the relationship between alexithymia and PD may
represent an artefact of the method and measures used (Lumley,
2000). Particularly, the TAS-20 dimensions “difﬁcult identifying
feelings” and “difﬁculty describing and communicating feelings”
correlate with different measures of negative affects (Cox et al.,
1995; Berthoz et al., 1999; Lumley, 2000; Marchesi et al., 2000;
Hintikka et al., 2001; Honkalampi et al., 2001). Therefore people
with negative emotional states (i.e. anxiety and depression) may
score high on these TAS-20 dimensions.
The present study does not allow any conclusion regarding
which view represents a better explanation of our results, because
our data may support both these hypotheses.
However, some methodological aspects limit the generalization
of our results.
First of all, given the small sample size of our PD women, ﬁrm
conclusions should be drawn from our results with precaution and
the present data need to be veriﬁed by using larger samples and
longer follow-up periods. Nevertheless the presence of PD symp-
toms, their severity and alexithymic features were frequently and
carefully monitored in our sample.
Second, we measured alexithymia only by a mean of a self-
rated questionnaire (TAS-20). This evaluation should be affected,
on the one hand, by the hampered ability of introspection, which
might characterized alexithymic people, and, on the other hand,
by the maintained ability of these subjects to recognize and report
in an undifferentiated manner negative affect on a questionnaire,
whose score is highly correlated with anxiety, depression or
neuroticism.
Third, we studied alexithymia and PD in a particular setting,
represented by pregnant women; therefore one can assume that
our data can be poorly generalized to other PD patients. However,
no study has demonstrated that PD symptomatology occurring in
pregnancy is different to that occurring in other conditions.
Nevertheless, in our sample only a minority of women showed
during pregnancy a PD severe enough to need a treatment: in fact
only 14% of women received a cognitive-behaviour therapy. There-
fore, our data can be generalized to subjects affected by mild-
moderate PD.
Fourth, PD was not diagnosed by a psychiatrist and therefore
our data might be poorly reliable.
However, the PD was diagnosed using the PRIME-MD, an
interview performed to evaluated mental disorders in primary
care, which showed a good reliability between diagnoses obtained
by trained physicians and those obtained by psychiatrists (Spitzer
et al., 1994). Moreover, the PRIME-MD showed good speciﬁcity
(99%) and sensitivity (57%) in detecting PD in primary care (Spitzer
et al., 1994).
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